A detailed history of Brevan Howard Capital Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 14,252 shares of AKRO stock, worth $404,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,252
Previous 10,191 39.85%
Holding current value
$404,329
Previous $239,000 70.71%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.45 - $29.34 $87,108 - $119,149
4,061 Added 39.85%
14,252 $408,000
Q2 2024

Aug 14, 2024

BUY
$18.31 - $24.62 $186,597 - $250,902
10,191 New
10,191 $239,000

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.32B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.